GlaxoSmithKline pledged not to file patents to make drugs more affordable to poor countries. Any GSK drugs that are included in the list of the World Health Organization's important medicines will be included automatically.
Medicines
Breaking News
GlaxoSmithKline (GSK.L) said on Wednesday it would shed "several hundred" U.S. commercial jobs and a similar number of research positions as it restructures operations in its biggest market, where drug sales are flagging.
Thermo Fisher Scientific has pledged to correct a glitch in software used to analyze data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors.
Patients with a single illness who take many drugs have an increased risk of being admitted to hospital, but for patients with multiple conditions, taking many medicines is now associated with a near-normal risk of admission.
Subscribe to VCpost newsletter
Most Popular
- How to Protect Yourself from Check Fraud: Tips and Best Practices
- Mobi: Empowering Consumer Product Companies with Real-time Sales Data
- Exploring the Future of Economic Growth: The Top 5 Special Economic Zones to Watch in 2023
- David Tomassoni (Salvaje): How the Hospitality Industry has Rebounded in the Post-Pandemic World
- How Test Automation Tools are Revolutionizing the Software Development Process
- From Shark Tank to Main Street: Kevin Harrington’s New Fintech Platform is Making Investing in Small Businesses Easier Than Ever
- Meet Kelcy Warren: The CEO Behind Energy Transfer
- World TradeX Creates Nft'S And Digital Coins With Intrinsic Value
